Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001319111-17-000005
Filing Date
2017-02-07
Accepted
2017-02-07 08:42:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 r13gPhibroAnimal_1216.txt SC 13G 5740
  Complete submission text file 0001319111-17-000005.txt   7669
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88114 | Film No.: 17577308
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3333 PIEDMONT ROAD NE SUITE 1500 ATLANTA GA 30305
Business Address 3333 PIEDMONT ROAD NE SUITE 1500 ATLANTA GA 30305 404-845-7700
RidgeWorth Capital Management LLC (Filed by) CIK: 0001319111 (see all company filings)

EIN.: 581604573 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G